Advertisement

Thyroid Cancer pp 201-205 | Cite as

Thyroid Lymphoma

Chapter
Part of the Endocrine Updates book series (ENDO, volume 32)

Abstract

Although the incidence (or at least the clinical presentation) of thyroid malignancies has been increasing in recent years, clinically significant thyroid cancers remain far less common than autoimmune thyroid diseases, Graves’ disease, and Hashimoto’s thyroiditis. Further, of the different pathological types of thyroid cancer, thyroid lymphomas are rare, representing less than 5% of thyroid neoplasms. Therefore, thyroid lymphomas are only encountered infrequently in clinical practice, for example, approximately two patients per year in a major referral center. Nevertheless, awareness and recognition of this condition are important because it is typically symptomatic and it may be amenable to therapy. Lymphomatous involvement of the thyroid gland can be localized to the gland (“primary”) or may be one component of more widespread lymphoma. This distinction may sometimes be blurred when the disease is primarily located in the thyroid but is also present to a limited extent in other regions, such as in lymph nodes adjacent to the thyroid. Viewed from another perspective, less than 1% of non-Hodgkin lymphomas present with primary thyroid involvement.

Keywords

Autoimmune thyroid diseases B-cell Graves’ disease Hashimoto’s thyroiditis MALT Thyroid neoplasms Treatment of lymphoma 

References

  1. 1.
    Thieblemont C, Mayer A, Dumontet C, Barbier Y, Callet-Bauchu E, Felman P, et al. Primary thyroid lymphoma is a heterogeneous disease. J Clin Endocrinol Metab. 2002;87:105–11.PubMedCrossRefGoogle Scholar
  2. 2.
    Ansell SM, Grant CS, Habermann TM. Primary ­thyroid lymphoma. Semin Oncol. 1999;26:316–23.PubMedGoogle Scholar
  3. 3.
    Miller BS, Gauger PG. Thyroid lymphoma arising from Hashimoto’s thyroiditis. J Clin Endocrinol Metab. 2006;91:3711–12.PubMedCrossRefGoogle Scholar
  4. 4.
    Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J. Lymphoma classification: from controversy to consensus - the R.E.A.L. and WHO Classification of lymphoid neoplasms. Ann Oncol. 2000;11(1):3–10.PubMedCrossRefGoogle Scholar
  5. 5.
    Derringer GA, Thompson LD, Frommelt RA, Bijwaard KE, Heffess CS, Abbondanzo SL. Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. Am J Surg Pathol. 2000;24:623–39.PubMedCrossRefGoogle Scholar
  6. 6.
    Ruggiero FP, Frauenhoffer E, Stack Jr BC. Thyroid lymphoma: a single institution’s experience. Otolaryngol Head Neck Surg. 2005;133:888–96.PubMedCrossRefGoogle Scholar
  7. 7.
    Koida S, Tsukasaki K, Tsuchiya T, Harasawa H, Fukushima T, Yamada Y, et al. Primary T-cell lymphoma of the thyroid gland with chemokine receptors of Th1 phenotype complicating autoimmune thyroiditis. Haematologica. 2007;92:e37–40.PubMedCrossRefGoogle Scholar
  8. 8.
    Yang H, Li J, Shen T. Primary T-cell lymphoma of the thyroid: case report and review of the literature. Med Oncol. 2008;25:462–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Motoi N, Ozawa Y. Malignant T-cell lymphoma of the thyroid gland associated with Hashimoto’s thyroiditis. Pathol Int. 2005;55:425–30.PubMedCrossRefGoogle Scholar
  10. 10.
    Kato I, Tajima K, Suchi T, Aozasa K, Matsuzuka F, Kuma K, et al. Chronic thyroiditis as a risk factor of B-cell lymphoma in the thyroid gland. Jpn J Cancer Res. 1985;76:1085–90.PubMedGoogle Scholar
  11. 11.
    Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med. 1985;312:601–4.PubMedCrossRefGoogle Scholar
  12. 12.
    McLachlan SM, McGregor A, Rees Smith B, Hall R. Thyroid-autoantibody synthesis by Hashimoto thyroid lymphocytes. Lancet. 1979;1(8108):162–3.PubMedCrossRefGoogle Scholar
  13. 13.
    McLachlan SM, Rapoport B. The molecular biology of thyroid peroxidase: cloning, expression and role as autoantigen in autoimmune thyroid disease. Endocr Rev. 1992;13:192–206.PubMedGoogle Scholar
  14. 14.
    Yamauchi A, Tomita Y, Takakuwa T, Hoshida Y, Nakatsuka S, Sakamoto H, et al. Polymerase chain reaction-based clonality analysis in thyroid lymphoma. Int J Mol Med. 2002;10:113–7.PubMedGoogle Scholar
  15. 15.
    Moshynska OV, Saxena A. Clonal relationship between Hashimoto thyroiditis and thyroid lymphoma. J Clin Pathol. 2008;61:438–44.PubMedCrossRefGoogle Scholar
  16. 16.
    Lam KY, Lo CY, Kwong DL, Lee J, Srivastava G. Malignant lymphoma of the thyroid. A 30-year clinicopathologic experience and an evaluation of the presence of Epstein-Barr virus. Am J Clin Pathol. 1999;112:263–70.PubMedGoogle Scholar
  17. 17.
    Mack LA, Pasieka JL. An evidence-based approach to the treatment of thyroid lymphoma. World J Surg. 2007;31:978–86.PubMedCrossRefGoogle Scholar
  18. 18.
    Hyjek E, Isaacson PG. Primary B cell lymphoma of the thyroid and its relationship to Hashimoto’s thyroiditis. Hum Pathol. 1988;19:1315–26.PubMedCrossRefGoogle Scholar
  19. 19.
    Chen HI, Akpolat I, Mody DR, Lopez-Terrada D, De Leon AP, Luo Y, et al. Restricted kappa/lambda light chain ratio by flow cytometry in germinal center B cells in Hashimoto thyroiditis. Am J Clin Pathol. 2006;125:42–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Wozniak R, Beckwith L, Ratech H, Surks MI. Maltoma of the thyroid in a man with Hashimoto’s thyroiditis. J Clin Endocrinol Metab. 1999;84:1206–9.PubMedGoogle Scholar
  21. 21.
    Lovchik J, Lane MA, Clark DP. Polymerase chain reaction-based detection of B-cell clonality in the fine needle aspiration biopsy of a thyroid mucosa-associated lymphoid tissue (MALT) lymphoma. Hum Pathol. 1997;28:989–92.PubMedCrossRefGoogle Scholar
  22. 22.
    Hsi ED, Singleton TP, Svoboda SM, Schnitzer B, Ross CW. Characterization of the lymphoid infiltrate in Hashimoto thyroiditis by immunohistochemistry and polymerase chain reaction for immunoglobulin heavy chain gene rearrangement. Am J Clin Pathol. 1998;110:327–33.PubMedGoogle Scholar
  23. 23.
    Kato K, Ohshima K, Shiokawa S, Shibata T, Suzumiya J, Kikuchi M. Rearrangement of immunoglobulin heavy and light chains and VH family in thyroid and salivary gland lymphomas. Pathol Int. 2002;52:747–54.PubMedCrossRefGoogle Scholar
  24. 24.
    Hummel M, Oeschger S, Barth TF, Loddenkemper C, Cogliatti SB, Marx A, et al. Wotherspoon criteria combined with B cell clonality analysis by advanced polymerase chain reaction technology discriminates covert gastric marginal zone lymphoma from chronic gastritis. Gut. 2006;55:782–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Saxena A, Alport EC, Moshynska O, Kanthan R, Boctor MA. Clonal B cell populations in a minority of patients with Hashimoto’s thyroiditis. J Clin Pathol. 2004;57:1258–63.PubMedCrossRefGoogle Scholar
  26. 26.
    Laing RW, Hoskin P, Hudson BV, Hudson GV, Harmer C, Bennett MH, et al. The significance of MALT histology in thyroid lymphoma: a review of patients from the BNLI and Royal Marsden Hospital. Clin Oncol (R Coll Radiol). 1994;6:300–4.CrossRefGoogle Scholar
  27. 27.
    Tsang RW, Gospodarowicz MK, Pintilie M, Wells W, Hodgson DC, Sun A, et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol. 2003;21:4157–64.PubMedCrossRefGoogle Scholar
  28. 28.
    Basu S, Li G, Bural G, Alavi A. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility. Acta Radiol. 2009;50:201–4.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Division of Endocrinology, Diabetes, and Metabolism, Department of MedicineCedars-Sinai Medical CenterLos AngelesUSA

Personalised recommendations